| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Medical Officer | Chief Medical Officer
2 companies
Rojkjaer Lisa is a Chief Medical Officer at VIRX, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 7 sales. Those positions are worth an estimated $1.1M at current prices.
Rojkjaer Lisa's largest disclosed position is in RIGL as EVP, Chief Medical Officer, worth about $1.0M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2023 | VIRX Viracta Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 2,156 | $1.68 | $3,624.67 | -4.3% | |
| Nov 28, 2022 | VIRX Viracta Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 2,116 | $2.72 | $5,754.04 | -4.4% | |
| Aug 26, 2022 | VIRX Viracta Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 2,190 | $4.01 | $8,785.84 | -4.7% | |
| May 26, 2022 | VIRX Viracta Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 2,154 | $1.90 | $4,094.97 | -4.9% | |
| Feb 28, 2022 | VIRX Viracta Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 2,395 | $2.78 | $6,656.90 | -5.6% | |
| Nov 29, 2021 | VIRX Viracta Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 4,541 | $4.81 | $21,847.46 | -10.6% |